波士顿1型人工角膜的玻璃体视网膜并发症
该回顾性介入性病例系列纳入2008至2017年在蒙特利尔大学中心医院接受波士顿人工角膜(KPro)植入的114例患者共132眼,随访至少1年。平均随访68.2个月,61.4%的眼发生术后玻璃体视网膜并发症,最常见为视网膜前膜形成(38.6%),视网膜脱离是唯一与较差视力结局显著相关的并发症(p=0.001)。
要点
- KPro术后玻璃体视网膜并发症发生率高,需在术后早期和中期频繁监测。
- 视网膜前膜形成为最常见并发症(38.6%),其次为视网膜脱离(15.2%)。
- 视网膜脱离是唯一与较差视力结局显著相关的并发症(p=0.001)。
核心结论
- 多数KPro眼会发生潜在致盲的继发并发症,需频繁监测,尤其是术后早期和中期。
- KPro眼视力结局显著改善,包括发生术后玻璃体视网膜并发症的眼。
研究设计与样本
- 回顾性、介入性病例系列。
- 纳入2008至2017年在Centre Hospitalier de l'Université de Montréal接受KPro植入的114例患者共132眼,随访至少1年。
主要发现
- 平均随访68.2个月,61.4%的眼发生术后玻璃体视网膜并发症。
- 最常见并发症为视网膜前膜形成(38.6%,n=51),其次为视网膜脱离(15.2%,n=20)、黄斑囊样水肿(12.1%,n=16)、视网膜前膜(9.8%,n=13)、眼内炎(9.1%,n=12)、无菌性玻璃体炎(7.6%,n=10)、玻璃体积血(6.8%,n=9)、脉络膜脱离(3.0%,n=4)和视网膜中央静脉阻塞(0.7%,n=1)。
- 无并发症组BCVA从1.74±0.33 logMAR改善至1.33±0.83 logMAR,并发症组从1.74±0.36 logMAR改善至1.52±0.83 logMAR,组间差异无统计学意义(p=0.231)。
- 视网膜脱离是唯一与较差视力结局显著相关的并发症(p=0.001)。
临床怎么用
- 对KPro术后患者,尤其是术后早期和中期,应进行频繁监测以早期发现玻璃体视网膜并发症。
- 出现视网膜脱离时需积极处理,因其与较差视力结局显著相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the incidence of vitreoretinal complications, treatment modalities, and the visual outcomes in a large cohort of eyes that underwent Boston Keratoprosthesis (KPro) implantation. DESIGN: Retrospective, interventional case series. METHODS: 132 eyes of 114 patients who underwent KPro implantation at the Centre Hospitalier de l'Université de Montréal from 2008 to 2017 were included with at least 1 year follow-up. Charts were reviewed and data was collected, including demographics, initial corneal indication for surgery, posterior segment complications, preoperative and postoperative visual acuity. RESULTS: Mean follow-up was 68.2 months and 61.4% of eyes developed postoperative vitreoretinal complications (VRC). The most common VRC was RPM formation (38.6%, n=51) followed by RD (15.2%, n=20), CME (12.1%, n=16), ERM (9.8%, n=13), endophthalmitis (9.1%, n=12), sterile vitritis (7.6%, n=10), vitreous hemorrhage (6.8%, n=9), choroidal detachment (3.0%, n=4) and central retinal vein occlusion (0.7%, n=1). BCVA improved in the no VRC group from 1.74 ± 0.33 logMAR to 1.33±0.83 logMAR and in the VRC group from 1.74±0.36 logMAR to 1.52±0.83 logMAR, without any statistically significant intergroup differences (p=0.231). RD was the only significant complication associated with poorer visual outcomes (p=0.001). CONCLUSION: Potentially blinding secondary complications occur in the majority of patients and frequent monitoring is necessary, specifically in the early and intermediate postoperative periods. This study evidenced significant improvements in visual outcomes of KPro eyes, including those that developed postoperative vitreoretinal complications.
引用
- Khair D, Salimi A, Harissi-Dagher M, et al. Vitreoretinal Complications in Boston Keratoprosthesis Type 1. Am J Ophthalmol. 2021. PMID: 34107311. doi:10.1016/j.ajo.2021.06.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。